Latest Financial Results
Q3 2020
Quarter Ended Sep 30, 2020
Stock Information
Symbol
OTCQB: ZIVOPrice
Change
Volume
52 week Low/High
Day Low/High
Company Overview
ZIVO Bioscience, Inc is dedicated to the development and commercialization of nutritional compounds and bioactive molecules created by its proprietary algal strains. ZIVO is currently in pre-revenue status. The Company is a licensor of internally developed intellectual property in the form of proprietary algae cultures, extracts, derivatives, product and ingredient concepts.
The company is targeting the following applications:
- Human Dietary Supplements & Nutraceuticals | Food Ingredients
- Animal Feed, Dietary Supplements & Drug Development
- Pharmaceuticals for Human Use
Investor Relations
Zivo Bioscience, Inc.
2804 Orchard Lake Road
Suite 202
Keego Harbor, MI 48320
T: 248-452-9866 x150
investor@zivobioscience.com
Transfer Agent
Interwest Transfer Co., Inc.
1981 Murray Holladay Road
Suite 100
Salt Lake City, UT 84117
T: 801-272-9294
www.interrwesttc.com